Related references
Note: Only part of the references are listed.The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target
Laura S. Moye et al.
CEPHALALGIA (2019)
Hypocretin Mediates Sleep and Wake Disturbances in a Mouse Model of Traumatic Brain Injury
Hannah E. Thomasy et al.
JOURNAL OF NEUROTRAUMA (2019)
Delta opioid receptor agonists are effective for multiple types of headache disorders
Laura S. Moye et al.
NEUROPHARMACOLOGY (2019)
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
David W. Dodick
CEPHALALGIA (2019)
Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide
Cristina Moldovan Loomis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Role of signalling molecules in behaviours mediated by the delta opioid receptor agonist SNC80
Isaac J. Dripps et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Headache in mitochondrial disorders
Josef Finsterer et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
PACAP and its receptors in cranial arteries and mast cells
Inger Jansen-Olesen et al.
JOURNAL OF HEADACHE AND PAIN (2018)
PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma
James A. Waschek et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Targeted Orexin and Hypothalamic Neuropeptides for Migraine
Lauren C. Strother et al.
NEUROTHERAPEUTICS (2018)
Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine
Anne Luise Haulund Vollesen et al.
NEUROTHERAPEUTICS (2018)
Targeted Nitric Oxide Synthase Inhibitors for Migraine
Amynah A. Pradhan et al.
NEUROTHERAPEUTICS (2018)
History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment
Stewart J. Tepper
HEADACHE (2018)
Soluble guanylyl cyclase is a critical regulator of migraine-associated pain
Manel Ben Aissa et al.
CEPHALALGIA (2018)
Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients
Song Guo et al.
CEPHALALGIA (2017)
Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine
Frank L. Rice et al.
CEPHALALGIA (2017)
Targeting delta opioid receptors for pain treatment: drugs in phase I and II clinical development
Viola Spahn et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Biology of Neuropeptides: Orexinergic Involvement in Primary Headache Disorders
Philip R. Holland
HEADACHE (2017)
Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache
Rodrigo Noseda et al.
HEADACHE (2017)
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Valery L. Feigin et al.
LANCET NEUROLOGY (2017)
Human models of migraine - short-term pain for long-term gain
Messoud Ashina et al.
NATURE REVIEWS NEUROLOGY (2017)
Association of Posttraumatic Stress Disorder With rs2267735 in the ADCYAP1R1 Gene: A Meta-Analysis
Mackenzie J. Lind et al.
JOURNAL OF TRAUMATIC STRESS (2017)
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention
Jennifer Y. Xie et al.
CEPHALALGIA (2017)
Change in brain network connectivity during PACAP38-induced migraine attacks A resting-state functional MRI study
Faisal Mohammad Amin et al.
NEUROLOGY (2016)
Pituitary Adenylate Cyclase-Activating Polypeptide Disrupts Motivation, Social Interaction, and Attention in Male Sprague Dawley Rats
Rachel J. Donahue et al.
BIOLOGICAL PSYCHIATRY (2016)
Delta-opioid receptors as targets for migraine therapy
Andrew Charles et al.
CURRENT OPINION IN NEUROLOGY (2016)
Release of PACAP-38 in episodic cluster headache patients - an exploratory study
Bernadett Tuka et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Medication-overuse headache: risk factors, pathophysiology and management
Hans-Christoph Diener et al.
NATURE REVIEWS NEUROLOGY (2016)
THE DELTA OPIOID RECEPTOR TOOL BOX
Ana Vicente-Sanchez et al.
NEUROSCIENCE (2016)
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
Erica M. Richards et al.
PSYCHOPHARMACOLOGY (2016)
Molecular Pharmacology of δ-Opioid Receptors
Louis Gendron et al.
PHARMACOLOGICAL REVIEWS (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
Evidence for orexinergic mechanisms in migraine
Jan Hoffmann et al.
NEUROBIOLOGY OF DISEASE (2015)
Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine
Simon Akerman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis
Almira Chabi et al.
CEPHALALGIA (2015)
Reduced CSF hypocretin-1 levels are associated with cluster headache
Mads Barloese et al.
CEPHALALGIA (2015)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Faisal Mohammad Amin et al.
BRAIN (2014)
d- Opioid receptor agonists inhibit migraine- related hyperalgesia, aversive state and cortical spreading depression in mice
Amynah A. Pradhan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: Possible involvement of mast cells
Deepak K. Bhatt et al.
CEPHALALGIA (2014)
Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects
Stephen L. Lowe et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Motivational activation: a unifying hypothesis of orexin/hypocretin function
Stephen V. Mahler et al.
NATURE NEUROSCIENCE (2014)
Delta Opioid Receptors Presynaptically Regulate Cutaneous Mechanosensory Neuron Input to the Spinal Cord Dorsal Horn
Rita Bardoni et al.
NEURON (2014)
DUAL OREXIN RECEPTOR ANTAGONIST 12 INHIBITS EXPRESSION OF PROTEINS IN NEURONS AND GLIA IMPLICATED IN PERIPHERAL AND CENTRAL SENSITIZATION
R. J. Cady et al.
NEUROSCIENCE (2014)
Characterization of a novel model of chronic migraine
Amynah A. Pradhan et al.
PAIN (2014)
Neurophysiology of HCN channels: From cellular functions to multiple regulations
Chao He et al.
PROGRESS IN NEUROBIOLOGY (2014)
Pituitary adenylate cyclase activating polypeptide and migraine
Alessandro S. Zagami et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models
Deepak K. Bhatt et al.
CEPHALALGIA (2013)
Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients
Bernadett Tuka et al.
CEPHALALGIA (2013)
Migraine: a brain state
Andrew Charles
CURRENT OPINION IN NEUROLOGY (2013)
Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
Andrew M. Blumenfeld et al.
HEADACHE (2013)
Chronic inflammatory injury results in increased coupling of delta opioid receptors to voltage-gated Ca2+ channels
Amynah Pradhan et al.
MOLECULAR PAIN (2013)
Cortical spreading depression and migraine
Andrew C. Charles et al.
NATURE REVIEWS NEUROLOGY (2013)
PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress
Michael L. Lehmann et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Opioid receptors: distinct roles in mood disorders
Pierre-Eric Lutz et al.
TRENDS IN NEUROSCIENCES (2013)
Anti-superoxide and anti-peroxynitrite strategies in pain suppression
Kali Janes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Ligand-directed signalling within the opioid receptor family
Amynah A. Pradhan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers
Faisal Mohammad Amin et al.
CEPHALALGIA (2012)
Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38
Michael Baun et al.
CEPHALALGIA (2012)
Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR
Jinsong Peng et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Migraine: Maladaptive Brain Responses to Stress
Nasim Maleki et al.
HEADACHE (2012)
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
Adrienn Markovics et al.
NEUROBIOLOGY OF DISEASE (2012)
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter et al.
PHARMACOLOGICAL REVIEWS (2012)
Increase in CGRP- and nNOS-immunoreactive neurons in the rat trigeminal ganglion after infusion of an NO donor
Anne Dieterle et al.
CEPHALALGIA (2011)
Orexins and their receptors from fish to mammals: A comparative approach
Kari K. Y. Wong et al.
GENERAL AND COMPARATIVE ENDOCRINOLOGY (2011)
Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor
Kerry J. Ressler et al.
NATURE (2011)
Migraine preventive drugs differentially affect cortical spreading depression in rat
Volodymyr Borysovych Bogdanov et al.
NEUROBIOLOGY OF DISEASE (2011)
The delta opioid receptor: an evolving target for the treatment of brain disorders
Amynah A. Pradhan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers
Milena De Felice et al.
BRAIN (2010)
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
M. R. Bruchas et al.
BRAIN RESEARCH (2010)
Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice
E. A. Bates et al.
CEPHALALGIA (2010)
Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache
Hans Olav Hoivik et al.
CEPHALALGIA (2010)
Nitric oxide synthase (NOS) in the trigeminal vascular system and other brain structures related to pain in rats
Roshni Ramachandran et al.
NEUROSCIENCE LETTERS (2010)
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
Sharron H. Francis et al.
PHARMACOLOGICAL REVIEWS (2010)
PACAP38 induces migraine-like attacks in patients with migraine without aura
Henrik Winther Schytz et al.
BRAIN (2009)
The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats
Gail Pereira Do Carmo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Discovery of the nitric oxide signaling pathway and targets for drug development
Nathan S. Bryan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Reward Processing by the Opioid System in the Brain
Julie Le Merrer et al.
PHYSIOLOGICAL REVIEWS (2009)
Excessive opioid use and the development of chronic migraine
Marcelo E. Bigal et al.
PAIN (2009)
Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid
P. Sarchielli et al.
CEPHALALGIA (2008)
Chronic migraine in the population - Burden, diagnosis, and satisfaction with treatment
Marcelo E. Bigal et al.
NEUROLOGY (2008)
The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache
Jes Olesen
PHARMACOLOGY & THERAPEUTICS (2008)
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers
Steffen Birk et al.
REGULATORY PEPTIDES (2007)
Pharmacological approaches to managing migraine and associated comorbidities - Clinical considerations for monotherapy versus polytherapy
Stephen D. Silberstein et al.
HEADACHE (2007)
Trafficking of δ-opioid receptors and other G-protein-coupled receptors:: implications for pain and analgesia
Catherine M. Cahill et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat
P. R. Holland et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
NF-κB activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks
P. Sarchielli et al.
CEPHALALGIA (2006)
Suppression of cortical spreading depression in migraine prophylaxis
C Ayata et al.
ANNALS OF NEUROLOGY (2006)
Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception
PR Holland et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle
MG Lee et al.
JOURNAL OF NEUROSCIENCE (2005)
Interactions between δ and μ opioid Agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys:: Studies with SNC80 [(+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin
GW Stevenson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
A comparison of the antinociceptive and adverse effects of the μ-opioid agonist morphine and the δ-opioid agonist SNC80
EL Gallantine et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods
R Taffi et al.
CEPHALALGIA (2005)
Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ
D Burdakov et al.
JOURNAL OF NEUROSCIENCE (2005)
Efficacy of coenzyme Q10 in migraine prophylaxis:: A randomized controlled trial
PS Sándor et al.
NEUROLOGY (2005)
Persistent pain and stress activate pain-inhibitory orexin pathways
S Watanabe et al.
NEUROREPORT (2005)
Chronic daily headache with analgesic overuse -: Epidemiology and impact on quality of life
R Colás et al.
NEUROLOGY (2004)
Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area
T Bartsch et al.
PAIN (2004)
Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia
F Mennicken et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Hypothalamic orexin neurons regulate arousal according to energy balance in mice
A Yamanaka et al.
NEURON (2003)
Increased frequency of migraine in narcoleptic patients: a confirmatory study
N Dahmen et al.
CEPHALALGIA (2003)
Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis
JC Eisenach et al.
PAIN (2003)
Convulsant activity of a non-peptidic δ-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats
DC Broom et al.
PSYCHOPHARMACOLOGY (2002)
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Nuclear factor-κB as a molecular target for migraine therapy
U Reuter et al.
ANNALS OF NEUROLOGY (2002)
Use of opioid medications for chronic noncancer pain syndromes in primary care
MC Reid et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2002)
Delayed inflammation in rat meninges: implications for migraine pathophysiology
U Reuter et al.
BRAIN (2001)
Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP)
H Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Antisense imaging of gene expression in the brain in vivo
NY Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis
A Pardutz et al.
NEUROREPORT (2000)
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
C Peyron et al.
NATURE MEDICINE (2000)
Share Paper
